F
Frank Riske
Researcher at Genzyme
Publications - 12
Citations - 701
Frank Riske is an academic researcher from Genzyme. The author has contributed to research in topics: Filtration & Gene delivery. The author has an hindex of 7, co-authored 12 publications receiving 614 citations.
Papers
More filters
Journal ArticleDOI
Integrated continuous production of recombinant therapeutic proteins
Veena Warikoo,Rahul Godawat,Kevin Brower,Sujit Jain,Daniel Cummings,Elizabeth Simons,Johnson Timothy,Jason Walther,Marcella Yu,Benjamin Wright,Jean McLarty,Kenneth P. Karey,Chris Hwang,Weichang Zhou,Frank Riske,Konstantin Konstantinov +15 more
TL;DR: The first successful demonstration of the integration of a perfusion bioreactor and a four‐column periodic counter‐current chromatography system for the continuous capture of candidate protein therapeutics is reported, demonstrating the potential of integrated continuous bioprocessing as a universal platform for the manufacture of various kinds of therapeutic proteins.
Journal ArticleDOI
Periodic counter-current chromatography – design and operational considerations for integrated and continuous purification of proteins
TL;DR: This paper presents a theoretical and practical approach for designing a periodic counter-current chromatography operation as a continuous capture purification step that is integrated with a perfusion cell culture process.
Journal ArticleDOI
The use of chitosan as a flocculant in mammalian cell culture dramatically improves clarification throughput without adversely impacting monoclonal antibody recovery.
TL;DR: This paper examined chitosan as a flocculent of cells and cell particulates in NS0 culture harvest and the subsequent further clarification of this material by continuous flow centrifugation followed by depth and absolute filtration to improve material clarity and increasing material throughput.
Journal ArticleDOI
Affinity Chromatography: An Enabling Technology for Large-Scale Bioprocessing.
Karol M Łącki,Frank Riske +1 more
TL;DR: This mini‐review is to provide an overview of the history of bioprocess AC, the current state of platform processes based on affinity capture steps, the maturing field of custom developed biobrocess affinity resins, and the advantages of affinity capture‐based downstream processing in comparison to other forms of chromatography.
Journal ArticleDOI
A potential generic downstream process using Cibracon Blue resin at very high loading capacity produces a highly purified monoclonal antibody preparation from cell culture harvest.
Frank Riske,M. Smith,Manoj K. Menon,S. Goetschalck,I. V. Goidsenhoven,A. Krul,V. Pimpaneau,I. Renaers,N. Van Tichelt,K. Van Houdt,M. Hayes,C. Lawrence,R. Bigelow,J. B. Schroeder +13 more
TL;DR: A facile three column scalable production scheme, employing CB as the second column in the process was used to generate highly purified MAb from cell culture harvest derived from two media of very different compositions.